Drug Profile
TRG 2411
Alternative Names: Research programme: melanocortin 1 receptor agonists - Trega BiosciencesLatest Information Update: 01 Dec 2003
Price :
$50
*
At a glance
- Originator SYGNIS Pharma
- Class Obesity therapies; Small molecules
- Mechanism of Action Melanocortin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus; Obesity
Most Recent Events
- 01 Dec 2003 Discontinued - Preclinical for Diabetes mellitus in USA (unspecified route)
- 01 Dec 2003 Discontinued - Preclinical for Obesity in USA (unspecified route)
- 13 Aug 2003 No development reported - Preclinical for Diabetes mellitus in USA (unspecified route)